Literature DB >> 32647279

A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy.

Matthew R Peterson1, Yohannes Getiye1, Luiza Bosch1, Alyssa J Sanders1, Aspen R Smith1, Samantha Haller1, Kayla Wilson1, D Paul Thomas2, Guanglong He3.   

Abstract

Macrophage- and monocyte-derived cytokines are elevated in the myocardium of pressure-overloaded hearts, where they play critical roles in pathological remodeling. Caspase recruitment domain family member 9 (CARD9) regulates macrophage cytokine secretion, but its role in a transverse aortic constriction (TAC) model of pressure overload has not been evaluated. To investigate whether CARD9 may serve as a valuable therapeutic target, wild-type (WT) and CARD9-knockout mice were subjected to 3 months of TAC, and then cardiac function, hypertrophy, and fibrosis were analyzed. The expression of protein markers of myocardial autophagy and nuclear factor kappa B signaling was also investigated. At 1 month after TAC, cardiomyocyte contractile dynamics were measured in a separate cohort to further assess contractility and diastolic function. In WT but not CARD9-/- mice, TAC resulted in severe cardiomyocyte contractile dysfunction at 1 month and functional decrements in fractional shortening at 3 months in vivo. Furthermore, CARD9-/- mice did not develop cardiac fibrosis or hypertrophy. CARD9-/- mice also had decreased protein expression of inhibitor of κB kinase-α/β, decreased phosphorylation of p65, and increased expression of protein markers of autophagy. These findings suggest that CARD9 plays a role in pathological remodeling and cardiac dysfunction in mouse hearts subjected to TAC and should be investigated further.

Entities:  

Keywords:  CARD9; Hypertension; Inflammation; Pressure overload; TAC

Year:  2020        PMID: 32647279     DOI: 10.1038/s41440-020-0507-0

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  Transforming growth factor-β: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function.

Authors:  Navin K Kapur
Journal:  Circ Heart Fail       Date:  2011-01       Impact factor: 8.790

2.  A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65.

Authors:  Liping Zhang; Yewei Ma; Jiqiang Zhang; Jizhong Cheng; Jie Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-31       Impact factor: 8.311

3.  Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy.

Authors:  Z Sasson; P G Yock; L K Hatle; E L Alderman; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

Review 5.  Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation.

Authors:  Susanne Roth; Jürgen Ruland
Journal:  Trends Immunol       Date:  2013-03-20       Impact factor: 16.687

6.  Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes.

Authors:  S J Liu; W Zhou; R H Kennedy
Journal:  Am J Physiol       Date:  1999-01

7.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.

Authors:  L E Bautista; L M Vera; I A Arenas; G Gamarra
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

8.  Interleukin-1β induces a reversible cardiomyopathy in the mouse.

Authors:  Benjamin W Van Tassell; Ignacio M Seropian; Stefano Toldo; Eleonora Mezzaroma; Antonio Abbate
Journal:  Inflamm Res       Date:  2013-05-07       Impact factor: 4.575

9.  Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension.

Authors:  Gil F Salles; Roberto Fiszman; Claudia R L Cardoso; Elizabeth S Muxfeldt
Journal:  Hypertension       Date:  2007-07-16       Impact factor: 10.190

  9 in total
  5 in total

1.  CARD9: key player or bystander in cardiac remodeling under hypertension?

Authors:  Lei Xi
Journal:  Hypertens Res       Date:  2020-09-02       Impact factor: 3.872

Review 2.  Annual reports on hypertension research 2020.

Authors:  Masaki Mogi; Yukihito Higashi; Kanako Bokuda; Atsuhiro Ichihara; Daisuke Nagata; Atsushi Tanaka; Koichi Node; Yoichi Nozato; Koichi Yamamoto; Ken Sugimoto; Hirotaka Shibata; Satoshi Hoshide; Hitoshi Nishizawa; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-10-15       Impact factor: 3.872

Review 3.  CARD9 Regulation and its Role in Cardiovascular Diseases.

Authors:  Haina Zhang; Yeling Wang; Hongbo Men; Wenqian Zhou; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

5.  Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway.

Authors:  Lu Zhao; Zhixin Lan; Liang Peng; Lili Wan; Di Liu; Xia Tan; Chengyuan Tang; Guochun Chen; Hong Liu
Journal:  Cell Prolif       Date:  2022-06-22       Impact factor: 8.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.